134 related articles for article (PubMed ID: 38751874)
1. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial.
Mehramiri A; Shalilahmadi D; Mohamadianinejad SE; Kouti L; Hosseinpour Y
Iran J Med Sci; 2024 May; 49(5):313-321. PubMed ID: 38751874
[TBL] [Abstract][Full Text] [Related]
2. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study.
Farzin K; Kheiltash A; Tafakhori A; Nakhjiri NE; Sabet MS; Nayeri ND
BMC Neurol; 2024 Jan; 24(1):2. PubMed ID: 38166859
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of migraine with melatonin: a randomized controlled trial.
Alstadhaug KB; Odeh F; Salvesen R; Bekkelund SI
Neurology; 2010 Oct; 75(17):1527-32. PubMed ID: 20975054
[TBL] [Abstract][Full Text] [Related]
6. Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.
Gelfand AA; Allen IE; Grimes B; Irwin S; Qubty W; Greene K; Waung M; Powers SW; Szperka CL
Headache; 2023 Oct; 63(9):1314-1326. PubMed ID: 37466211
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
8. Effect of a traditional syrup from Citrus medica L. fruit juice on migraine headache: A randomized double blind placebo controlled clinical trial.
Jafarpour M; Yousefi G; Hamedi A; Shariat A; Salehi A; Heydari M
J Ethnopharmacol; 2016 Feb; 179():170-6. PubMed ID: 26721220
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
10. Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial.
Cao K; Han F; Lin A; Yang W; Zhao J; Zhang H; Ding Y; Xie W; Xu Y; Yu T; Wang X; Yang X; Zhou J; Hou Q; Yu L; Gao Y
BMC Complement Altern Med; 2016 Sep; 16(1):356. PubMed ID: 27618916
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Modified Wuzhuyu Decoction Granule ( ) for Migraine Patients with Cold and Stasis Obstructing Meridian Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Liu HW; Zou YH; Cao KG; Yu LH; Zhang Y; Fu CH; Ma DY
Chin J Integr Med; 2018 Jun; 24(6):409-414. PubMed ID: 28741060
[TBL] [Abstract][Full Text] [Related]
12. The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial.
Askari G; Nasiri M; Mozaffari-Khosravi H; Rezaie M; Bagheri-Bidakhavidi M; Sadeghi O
Nutrition; 2017 Jun; 38():74-79. PubMed ID: 28526386
[TBL] [Abstract][Full Text] [Related]
13. The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial.
Martami F; Togha M; Seifishahpar M; Ghorbani Z; Ansari H; Karimi T; Jahromi SR
Cephalalgia; 2019 Jun; 39(7):841-853. PubMed ID: 30621517
[TBL] [Abstract][Full Text] [Related]
14. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
15. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
[TBL] [Abstract][Full Text] [Related]
16. Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials).
Ailani J; Andrews JS; Rettiganti M; Nicholson RA
J Headache Pain; 2020 Oct; 21(1):123. PubMed ID: 33069214
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.
Gonçalves AL; Martini Ferreira A; Ribeiro RT; Zukerman E; Cipolla-Neto J; Peres MF
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1127-32. PubMed ID: 27165014
[TBL] [Abstract][Full Text] [Related]
18. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.
Kinfe TM; Pintea B; Muhammad S; Zaremba S; Roeske S; Simon BJ; Vatter H
J Headache Pain; 2015; 16():101. PubMed ID: 26631234
[TBL] [Abstract][Full Text] [Related]
19. Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial.
Izquierdo-Casas J; Comas-Basté O; Latorre-Moratalla ML; Lorente-Gascón M; Duelo A; Soler-Singla L; Vidal-Carou MC
Clin Nutr; 2019 Feb; 38(1):152-158. PubMed ID: 29475774
[TBL] [Abstract][Full Text] [Related]
20. Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine.
Ashina M; Cohen JM; Gandhi SK; Du E
Headache; 2021 Jun; 61(6):916-926. PubMed ID: 34115380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
